Hysbysiad contract
Adran I:
Endid
contractio
I.1) Enw a chyfeiriad
Department of Health and Social Care
39 Victoria Street
London
SW1H 0EU
UK
Person cyswllt: Jay Bains
E-bost: ccsinbox@dhsc.gov.uk
NUTS: UKI32
Cyfeiriad(au) rhyngrwyd
Prif gyfeiriad: https://www.gov.uk/government/organisations/department-of-health-and-social-care
Cyfeiriad proffil y prynwr: https://www.gov.uk/government/organisations/department-of-health-and-social-care
I.3) Cyfathrebu
Mae'r dogfennau caffael ar gael ar gyfer mynediad uniongyrchol anghyfyngedig a llawn, yn rhad ac am ddim ar:
https://health-family.force.com/s/Welcome
Gellir cael gwybodaeth ychwanegol o'r cyfeiriad uchod
Rhaid anfon tendrau neu geisiadau i gymryd rhan yn electronig at:
https://health-family.force.com/s/Welcome
Rhaid anfon tendrau neu geisiadau i gymryd rhan i'r cyfeiriad uchod:
Mae cyfathrebu electronig yn gofyn am ddefnyddio offer a dyfeisiau nad ydynt ar gael yn gyffredinol. Mae mynediad uniongyrchol anghyfgyfyngiedig a llawn i'r offer a dyfeisiau hyn yn bosibl, yn rhad ac am ddim, yn:
https://health-family.force.com/s/Welcome
I.4) Y math o awdurdod contractio
Gweinyddiaeth neu unrhyw awdurdod cenedlaethol neu ffederal arall, gan gynnwys eu his-adrannau rhanbarthol neu leol
I.5) Prif weithgaredd
Iechyd
Adran II: Gwrthrych
II.1) Cwmpas y caffaeliad
II.1.1) Teitl
DHSC: PCP: Evidence Summaries (4 lots) FY 24/25
Cyfeirnod: C294820
II.1.2) Prif god CPV
73200000
II.1.3) Y math o gontract
Gwasanaethau
II.1.4) Disgrifiad byr
The UK National Screening Committee (UK NSC) advises Ministers and the NHS in the 4 UK countries on all aspects of screening. The UK NSC makes recommendations on whether or not to introduce screening programmes for over 100 conditions. The evidence team, part of the UK NSC Secretariat, hosted by the Department of Health and Social Care, is responsible for managing the evidence review process to ensure UK NSC recommendations remain up to date.<br/><br/>The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries.Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises.<br/><br/>This contract has been divided into 4 lots. Each lot corresponds to the following lots<br/>Lot 1 Biliary atresia <br/>Lot 2 Group B strep<br/>Lot 3 Breast Risk Stratification<br/>Lot 4 Targeted Screening<br/>Contract Project Reference: C294820<br/>Contract term: 9 months with the option to extend for up to further 2 months.<br/>Estimated contract value (including extensions) for all the lots (4) is: £248,264 (excluding VAT), £297,916.80 (inclusive of VAT). Each lot (evidence maps) estimated value is: £62,066 (excluding VAT), £74,479.20 (inclusive of VAT)<br/><br/>The contracting authority considers that this future opportunity may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.<br/><br/>The opportunity will be available on the DHSC Atamis eTendering System. Select this link to access and register your organisation to the Atamis system https://health-family.force.com/s/Welcome, if you have not already done so.<br/>To find this opportunity in the eTendering system, select “Find Opportunities” and then search by project number or title. Once you have found the Opportunity, press the ‘Register Interest’ button to register your interest. This will make the project to appear on ‘My proposals and quotes’. From there you can review documents, send clarification messages, submit the response, or decline to respond, if you decide not to participate in the opportunity. For full details on the instruction to tender and terms of participations please refer to the Invitation to Tender document.<br/><br/>Deadline for submission: 21st October 2024 at 12 noon
II.1.5) Cyfanswm gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 248 264.00 GBP
II.1.6) Gwybodaeth am lotiau
Mae’r contract hwn wedi’i rannu’n lotiau:
Ydy
Gellir cyflwyno tendrau ar gyfer pob lot
Uchafswm y lotiau y gellir eu dyfarnu i un tendrwr: 2
II.2) Disgrifiad
Rhif y Lot 1
II.2.1) Teitl
Lot 1-Biliary atresia
II.2.2) Cod(au) CPV ychwanegol
73200000
II.2.3) Man cyflawni
Cod NUTS:
UKI32
II.2.4) Disgrifiad o’r caffaeliad
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot Lot 1 Biliary atresia
II.2.5) Meini prawf dyfarnu
Nid pris yw’r unig faen prawf dyfarnu a dim ond yn y dogfennau caffael y mae’r holl feini prawf wedi’u nodi
II.2.6) Gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 62 066.00 GBP
II.2.7) Hyd y contract, y cytundeb fframwaith neu’r system brynu ddynamig
Hyd mewn misoedd: 9
Gall y contract hwn gael ei adnewyddu: Ydy
Disgrifiad o’r adnewyddiadau:
Additional 2 months at the sole discretion of the Authority and no additional cost.
II.2.9) Gwybodaeth am y cyfyngiadau ar nifer yr ymgeiswyr a gaiff eu gwahodd
II.2.10) Gwybodaeth am amrywiadau
Derbynnir amrywiadau:
Na
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Rhif y Lot 2
II.2.1) Teitl
Lot 2-Group B strep
II.2.2) Cod(au) CPV ychwanegol
73200000
II.2.3) Man cyflawni
Cod NUTS:
UKI32
II.2.4) Disgrifiad o’r caffaeliad
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot 2 Group B strep
II.2.5) Meini prawf dyfarnu
Nid pris yw’r unig faen prawf dyfarnu a dim ond yn y dogfennau caffael y mae’r holl feini prawf wedi’u nodi
II.2.6) Gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 62 066.00 GBP
II.2.7) Hyd y contract, y cytundeb fframwaith neu’r system brynu ddynamig
Hyd mewn misoedd: 9
Gall y contract hwn gael ei adnewyddu: Ydy
Disgrifiad o’r adnewyddiadau:
Additional 2 months at the sole discretion of the Authority and no additional cost.
II.2.9) Gwybodaeth am y cyfyngiadau ar nifer yr ymgeiswyr a gaiff eu gwahodd
II.2.10) Gwybodaeth am amrywiadau
Derbynnir amrywiadau:
Na
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Rhif y Lot 3
II.2.1) Teitl
Lot 3-Decision analytic model for risk stratification in breast cancer screening
II.2.2) Cod(au) CPV ychwanegol
73200000
II.2.3) Man cyflawni
Cod NUTS:
UKI32
II.2.4) Disgrifiad o’r caffaeliad
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot 3 Decision Analytic Model for Risk Stratification
II.2.5) Meini prawf dyfarnu
Nid pris yw’r unig faen prawf dyfarnu a dim ond yn y dogfennau caffael y mae’r holl feini prawf wedi’u nodi
II.2.6) Gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 62 066.00 GBP
II.2.7) Hyd y contract, y cytundeb fframwaith neu’r system brynu ddynamig
Hyd mewn misoedd: 9
Gall y contract hwn gael ei adnewyddu: Ydy
Disgrifiad o’r adnewyddiadau:
Additional 2 months at the sole discretion of the Authority and no additional cost.
II.2.9) Gwybodaeth am y cyfyngiadau ar nifer yr ymgeiswyr a gaiff eu gwahodd
II.2.10) Gwybodaeth am amrywiadau
Derbynnir amrywiadau:
Na
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Rhif y Lot 4
II.2.1) Teitl
Lot 4-Targeted Screening
II.2.2) Cod(au) CPV ychwanegol
73200000
II.2.3) Man cyflawni
Cod NUTS:
UKI32
II.2.4) Disgrifiad o’r caffaeliad
The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries. Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises. This contract has been divided into 4 lots. This lot corresponds to Lot 4 Targeted Screening
II.2.5) Meini prawf dyfarnu
Nid pris yw’r unig faen prawf dyfarnu a dim ond yn y dogfennau caffael y mae’r holl feini prawf wedi’u nodi
II.2.6) Gwerth amcangyfrifedig
Gwerth heb gynnwys TAW: 62 066.00 GBP
II.2.7) Hyd y contract, y cytundeb fframwaith neu’r system brynu ddynamig
Hyd mewn misoedd: 9
Gall y contract hwn gael ei adnewyddu: Ydy
Disgrifiad o’r adnewyddiadau:
Additional 2 months at the sole discretion of the Authority and no additional cost.
II.2.9) Gwybodaeth am y cyfyngiadau ar nifer yr ymgeiswyr a gaiff eu gwahodd
II.2.10) Gwybodaeth am amrywiadau
Derbynnir amrywiadau:
Na
II.2.11) Gwybodaeth am opsiynau
Opsiynau:
Na
II.2.13) Gwybodaeth am Gronfeydd yr Undeb Ewropeaidd
Mae'r broses gaffael yn gysylltiedig â phrosiect a/neu raglen a ariennir gan gronfeydd yr Undeb Ewropeaidd:
Na
Section III: Gwybodaeth gyfreithiol, economaidd, ariannol a thechnegol
III.1) Amodau ar gyfer cymryd rhan
III.1.2) Statws economaidd ac ariannol
Meini prawf dethol fel y’u nodir yn y dogfennau caffael
III.2) Amodau sy’n gysylltiedig â’r contract
Section IV: Gweithdrefn
IV.1) Disgrifiad
IV.1.1) Y math o weithdrefn
Gweithdrefn agored
IV.1.8) Gwybodaeth am Gytundeb Caffael y Llywodraeth (GPA)
The procurement is covered by the Government Procurement Agreement:
Na
IV.2) Gwybodaeth weinyddol
IV.2.1) Cyhoeddiad blaenorol mewn perthynas â’r weithdrefn hon
Rhif yr hysbysiad yn OJ S:
2024/S 000-018132
IV.2.2) Terfyn amser i dendrau neu geisiadau i gymryd rhan ddod i law
Dyddiad:
21/10/2024
Amser lleol: 12:00
IV.2.4) Ym mha iaith/ieithoedd y gellir cyflwyno tendrau neu geisiadau i gymryd rhan
EN
IV.2.6) Yr isafswm cyfnod gofynnol i’r sawl sy’n tendro gynnal y tendr
Hyd mewn misoedd: 6 (o’r dyddiad a nodwyd i dendr ddod i law)
IV.2.7) Amodau ar gyfer agor tendrau
Dyddiad:
21/10/2024
Amser lleol: 12:00
Section VI: Gwybodaeth ategol
VI.1) Gwybodaeth am ailddigwydd
Caffaeliad cylchol yw hwn:
Na
VI.3) Gwybodaeth ychwanegol
The UK National Screening Committee (UK NSC) advises Ministers and the NHS in the 4 UK countries on all aspects of screening. The UK NSC makes recommendations on whether or not to introduce screening programmes for over 100 conditions. The evidence team, part of the UK NSC Secretariat, hosted by the Department of Health and Social Care, is responsible for managing the evidence review process to ensure UK NSC recommendations remain up to date.<br/><br/>The Department of Health and Social Care is looking to appoint a contractor/s to deliver Evidence summaries.Their purpose is to gauge if there have been significant developments in the evidence base on important questions identified in previous reviews on the same topic. They also establish if a current recommendation can be reaffirmed, establish if a topic is likely to benefit from further assessment through the development of different, more in depth, types of evidence product. More in-depth evidence products include systematic reviews, cost effectiveness models and disease modelling exercises.<br/><br/>This contract has been divided into 4 lots. Each lot corresponds to the following lots<br/>Lot 1 Biliary atresia <br/>Lot 2 Group B strep<br/>Lot 3 Breast Risk Stratification<br/>Lot 4 Targeted Screening<br/>Contract Project Reference: C294820<br/>Contract term: 9 months with the option to extend for up to further 2 months.<br/>Estimated contract value (including extensions) for all the lots (4) is: £248,264 (excluding VAT), £297,916.80 (inclusive of VAT). Each lot (evidence maps) estimated value is: £62,066 (excluding VAT), £74,479.20 (inclusive of VAT)<br/><br/>The contracting authority considers that this future opportunity may be suitable for economic operators that are small or medium enterprises (SMEs). However, any selection of tenderers will be based solely on the criteria set out for the procurement.<br/><br/>The opportunity will be available on the DHSC Atamis eTendering System. Select this link to access and register your organisation to the Atamis system https://health-family.force.com/s/Welcome, if you have not already done so.<br/>To find this opportunity in the eTendering system, select “Find Opportunities” and then search by project number or title. Once you have found the Opportunity, press the ‘Register Interest’ button to register your interest. This will make the project to appear on ‘My proposals and quotes’. From there you can review documents, send clarification messages, submit the response, or decline to respond, if you decide not to participate in the opportunity. For full details on the instruction to tender and terms of participations please refer to the Invitation to Tender document.<br/><br/>Deadline for submission: 21st October 2024 at 12 noon
VI.4) Gweithdrefnau adolygu
VI.4.1) Corff adolygu
The High Court
The Strand
London
WC2A 2LL
UK
Cyfeiriad(au) rhyngrwyd
URL: https://www.judiciary.uk/courts-and-tribunals/high-court/
VI.4.2) Corff sy’n gyfrifol am weithdrefnau cyfryngu
The High Court
Strand
London
WC2A 2LL
UK
E-bost: generaloffice@administrativecourtoffice.justice.gov.uk
Cyfeiriad(au) rhyngrwyd
URL: https://www.gov.uk/courts-tribunals
VI.4.4) Y gwasanaeth lle y gellir cael gwybodaeth am y weithdrefn adolygu
The High Court
Strand
London
WC2A 2LL
UK
E-bost: generaloffice@administrativecourtoffice.justice.gov.uk
Cyfeiriad(au) rhyngrwyd
URL: https://www.gov.uk/courts-tribunals
VI.5) Dyddiad anfon yr hysbysiad hwn
09/09/2024